Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350680
Max Phase: Preclinical
Molecular Formula: C48H79N4O13P
Molecular Weight: 951.15
Molecule Type: Small molecule
Associated Items:
ID: ALA3350680
Max Phase: Preclinical
Molecular Formula: C48H79N4O13P
Molecular Weight: 951.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCC/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C/CCCCCCCC)COP(=O)(O)OC[C@H](Nc1ccc([N+](=O)[O-])c2nonc12)C(=O)O
Standard InChI: InChI=1S/C48H79N4O13P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-44(53)61-37-40(64-45(54)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)38-62-66(59,60)63-39-42(48(55)56)49-41-35-36-43(52(57)58)47-46(41)50-65-51-47/h17-20,35-36,40,42,49H,3-16,21-34,37-39H2,1-2H3,(H,55,56)(H,59,60)/b19-17+,20-18-/t40?,42-/m0/s1
Standard InChI Key: JJGPEMHBCCAKID-WCMIBQGTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 951.15 | Molecular Weight (Monoisotopic): 950.5381 | AlogP: 12.66 | #Rotatable Bonds: 43 |
Polar Surface Area: 239.75 | Molecular Species: ACID | HBA: 14 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.89 | CX Basic pKa: | CX LogP: 13.57 | CX LogD: 7.96 |
Aromatic Rings: 2 | Heavy Atoms: 66 | QED Weighted: 0.01 | Np Likeness Score: 0.14 |
1. Woehlecke H, Pohl A, Alder-Baerens N, Lage H, Herrmann A.. (2003) Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2)., 376 (1): [PMID:12946267] [10.1042/bj20030886] |
Source(1):